Compare Amphastar Pharmaceuticals Inc (AMPH) vs Las Vegas Sands Corp. (LVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Las Vegas Sands Corp. — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Las Vegas Sands Corp. trades at $45.83 (market cap $29.44B). The key difference: Las Vegas Sands Corp. is far larger — about 33.9× Amphastar Pharmaceuticals Inc's market cap, and Las Vegas Sands Corp. pays a 2.64% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | LVS | |
|---|---|---|
Market Cap | $868.62M | $29.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $69.49 |
52-Week Low | $16.87 | $44.78 |
Enterprise Value | $1.27B | $41.33B |
Dividend Yield | — | 2.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →
